(RTTNews) – Nektar Therapeutics (NKTR) announced Friday the promotion of Jillian Thomsen to Senior Vice President (SVP) & Main Economical Officer. Thomsen has served as SVP, Finance & Main Accounting Officer of Nektar given that 2008, and is a crucial member of the Govt Committee.
Gil Labrucherie, the firm’s existing Chief Operating Officer & Main Economical Officer, will be departing the company to pursue a further possibility at a non-public biotechnology firm.
In April 2008, Thomsen was appointed Chief Accounting Officer at Nektar and joined the Executive Committee. She has more than 30 several years of finance and accounting experience.
In her latest part, Thomsen oversees accounting, money reporting, FP&A, Sarbanes-Oxley compliance, treasury, tax, medical outsourcing, and procurement features at the corporation. From 2006 to 2008, she served as Vice President, Finance and Controller of Nektar.
Prior to signing up for Nektar in 2006, Thomsen was Deputy Controller of Calpine Corp. from September 2002 to February 2006.
The sights and viewpoints expressed herein are the sights and viewpoints of the creator and do not essentially mirror those people of Nasdaq, Inc.